Corvus Pharmaceuticals, Inc. SEC filings CRVS

Corvus Pharmaceuticals, Inc. has 583 filings in SEC EDGAR's recent list, going back to Dec 8, 2014. Its latest annual report, Form 10-K, was filed on Mar 12, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.

Corvus Pharmaceuticals, Inc. SEC filings
Form Description Filed Period
10-Q Quarterly report Nov 5, 2026 Sep 30, 2026
8-K Current report
Results of operations
Nov 5, 2026 Nov 5, 2026
SCHEDULE 13G Ownership over 5% (passive) Aug 7, 2026 —
10-Q Quarterly report Aug 6, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 6, 2026 Aug 6, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Jul 27, 2026 —
8-K Current report
Officer or director change
Jul 22, 2026 Jul 21, 2026
4 Insider transaction Jun 15, 2026 Jun 11, 2026
4 Insider transaction Jun 15, 2026 Jun 11, 2026
4 Insider transaction Jun 15, 2026 Jun 11, 2026
4 Insider transaction Jun 15, 2026 Jun 11, 2026
4 Insider transaction Jun 15, 2026 Jun 11, 2026
8-K Current report
Shareholder vote results
Jun 12, 2026 Jun 11, 2026
4 Insider transaction May 20, 2026 May 18, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
SCHEDULE 13G Ownership over 5% (passive) May 15, 2026 —
8-K Current report
Regulation FD disclosure, Other events
May 14, 2026 May 14, 2026
S-8 Employee stock plan registration May 7, 2026 —
10-Q Quarterly report May 7, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 7, 2026 May 7, 2026
4 Insider transaction Apr 27, 2026 Apr 23, 2026
3 Initial insider ownership Apr 27, 2026 Apr 23, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Apr 27, 2026 —
DEFA14A Additional proxy material Apr 24, 2026 —
DEF 14A Proxy statement Apr 24, 2026 Jun 11, 2026
8-K Current report
Officer or director change
Apr 23, 2026 Apr 22, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 26, 2026 —
8-K Current report
Material agreement
Mar 13, 2026 Mar 13, 2026
424B5 Prospectus supplement Mar 13, 2026 —
S-3ASR Automatic shelf registration Mar 13, 2026 —
10-K Annual report Mar 12, 2026 Dec 31, 2025
8-K Current report
Results of operations
Mar 12, 2026 Mar 12, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 13, 2026 —
SCHEDULE 13D/A Amended ownership over 5% (active) Feb 5, 2026 —
4 Insider transaction Jan 30, 2026 Jan 28, 2026
SCHEDULE 13G Ownership over 5% (passive) Jan 30, 2026 —
SCHEDULE 13D/A Amended ownership over 5% (active) Jan 27, 2026 —
8-K Current report
Other events
Jan 23, 2026 Jan 21, 2026
424B5 Prospectus supplement Jan 23, 2026 —
S-3MEF Filing Jan 21, 2026 —
424B5 Prospectus supplement Jan 20, 2026 —
8-K Current report
Other events
Jan 20, 2026 Jan 20, 2026
8-K Current report
Regulation FD disclosure, Other events
Jan 20, 2026 Jan 20, 2026
4 Insider transaction Dec 8, 2025 Dec 4, 2025
4 Insider transaction Dec 8, 2025 Dec 4, 2025
4 Insider transaction Dec 8, 2025 Dec 4, 2025
4 Insider transaction Dec 8, 2025 Dec 4, 2025
10-Q Quarterly report Nov 4, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 4, 2025 Nov 4, 2025
SCHEDULE 13G Ownership over 5% (passive) Oct 17, 2025 —
4 Insider transaction Oct 6, 2025 Oct 2, 2025
3 Initial insider ownership Oct 6, 2025 Oct 2, 2025
8-K Current report
Officer or director change
Oct 2, 2025 Oct 2, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2025 —
10-Q Quarterly report Aug 7, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 7, 2025 Aug 7, 2025
4 Insider transaction Jul 1, 2025 Jun 27, 2025
4 Insider transaction Jul 1, 2025 Jun 27, 2025
4 Insider transaction Jun 16, 2025 Jun 12, 2025
4 Insider transaction Jun 16, 2025 Jun 12, 2025
4 Insider transaction Jun 16, 2025 Jun 12, 2025
4 Insider transaction Jun 16, 2025 Jun 12, 2025
8-K Current report
Shareholder vote results
Jun 13, 2025 Jun 12, 2025
4 Insider transaction Jun 6, 2025 Jun 4, 2025
8-K Current report
Regulation FD disclosure, Other events
Jun 4, 2025 Jun 4, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2025 —
SCHEDULE 13D/A Amended ownership over 5% (active) May 14, 2025 —
4 Insider transaction May 9, 2025 May 7, 2025
S-8 Employee stock plan registration May 8, 2025 —
10-Q Quarterly report May 8, 2025 Mar 31, 2025
8-K Current report
Results of operations, Regulation FD disclosure, Other events
May 8, 2025 May 8, 2025
SCHEDULE 13D/A Amended ownership over 5% (active) May 1, 2025 —
DEFA14A Additional proxy material Apr 25, 2025 —
DEF 14A Proxy statement Apr 25, 2025 Jun 12, 2025
4 Insider transaction Apr 9, 2025 Apr 8, 2025
3 Initial insider ownership Apr 9, 2025 Apr 8, 2025
8-K Current report
Officer or director change
Apr 9, 2025 Apr 8, 2025
10-K Annual report Mar 25, 2025 Dec 31, 2024
8-K Current report
Results of operations
Mar 25, 2025 Mar 25, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 13, 2025 —
8-K Current report
Regulation FD disclosure, Other events
Jan 13, 2025 Jan 13, 2025
4 Insider transaction Dec 23, 2024 Dec 20, 2024
4 Insider transaction Dec 23, 2024 Dec 20, 2024
4 Insider transaction Dec 23, 2024 Dec 20, 2024
4 Insider transaction Dec 23, 2024 Dec 20, 2024
8-K Current report
Regulation FD disclosure, Other events
Dec 18, 2024 Dec 18, 2024
10-Q Quarterly report Nov 12, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 12, 2024 Nov 12, 2024
8-K Current report
Material agreement
Oct 23, 2024 Oct 22, 2024
EFFECT Filing Aug 15, 2024 —
CORRESP Letter to the SEC Aug 13, 2024 —
UPLOAD Letter from the SEC Aug 13, 2024 —
S-3 Shelf registration Aug 6, 2024 —
10-Q Quarterly report Aug 6, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 6, 2024 Aug 6, 2024
SC 13G/A Amended ownership over 5% (passive) Aug 1, 2024 —
4 Insider transaction Jun 17, 2024 Jun 13, 2024
4 Insider transaction Jun 17, 2024 Jun 13, 2024
4 Insider transaction Jun 17, 2024 Jun 13, 2024
4 Insider transaction Jun 17, 2024 Jun 13, 2024
4 Insider transaction Jun 17, 2024 Jun 13, 2024
8-K Current report
Shareholder vote results
Jun 14, 2024 Jun 13, 2024
4 Insider transaction May 14, 2024 May 10, 2024
SC 13G/A Amended ownership over 5% (passive) May 13, 2024 —
SC 13G Ownership over 5% (passive) May 9, 2024 —
4 Insider transaction May 8, 2024 May 6, 2024
4 Insider transaction May 8, 2024 May 6, 2024
SC 13D/A Amended ownership over 5% (active) May 8, 2024 —
S-8 Employee stock plan registration May 7, 2024 —
10-Q Quarterly report May 7, 2024 Mar 31, 2024
4 Insider transaction May 7, 2024 May 6, 2024
4 Insider transaction May 7, 2024 May 6, 2024
8-K Current report
Material agreement
May 6, 2024 May 1, 2024
8-K Current report
Results of operations
May 6, 2024 May 6, 2024
424B5 Prospectus supplement May 3, 2024 —
8-K Current report
Other events
May 1, 2024 May 1, 2024
DEFA14A Additional proxy material Apr 26, 2024 —
DEF 14A Proxy statement Apr 26, 2024 Jun 13, 2024
10-K Annual report Mar 19, 2024 Dec 31, 2023
8-K Current report
Results of operations
Mar 19, 2024 Mar 19, 2024
4 Insider transaction Mar 1, 2024 Feb 28, 2024
SC 13G Ownership over 5% (passive) Feb 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 13, 2024 —
3 Initial insider ownership Feb 8, 2024 Feb 2, 2024
8-K Current report
Officer or director change, Other events
Jan 23, 2024 Jan 23, 2024
4 Insider transaction Dec 8, 2023 Dec 6, 2023
4 Insider transaction Dec 8, 2023 Dec 6, 2023
4 Insider transaction Dec 8, 2023 Dec 6, 2023
4 Insider transaction Dec 8, 2023 Dec 6, 2023
4 Insider transaction Dec 8, 2023 Dec 6, 2023
4 Insider transaction Dec 8, 2023 Dec 6, 2023
4 Insider transaction Dec 8, 2023 Dec 6, 2023
4 Insider transaction Dec 8, 2023 Dec 6, 2023
4 Insider transaction Dec 8, 2023 Dec 6, 2023
8-K Current report
Results of operations
Nov 7, 2023 Nov 7, 2023
10-Q Quarterly report Nov 7, 2023 Sep 30, 2023
8-K Current report
Other events
Sep 7, 2023 Sep 6, 2023
10-Q Quarterly report Aug 8, 2023 Jun 30, 2023
8-K Current report
Results of operations
Aug 8, 2023 Aug 8, 2023
8-K Current report
Shareholder vote results
Jun 21, 2023 Jun 15, 2023
4 Insider transaction Jun 20, 2023 Jun 15, 2023
4 Insider transaction Jun 20, 2023 Jun 15, 2023
4 Insider transaction Jun 20, 2023 Jun 15, 2023
4 Insider transaction Jun 20, 2023 Jun 15, 2023
4 Insider transaction Jun 20, 2023 Jun 15, 2023
4 Insider transaction Jun 20, 2023 Jun 15, 2023
4 Insider transaction May 16, 2023 May 15, 2023
EFFECT Filing May 8, 2023 —
10-Q Quarterly report May 8, 2023 Mar 31, 2023
8-K Current report
Results of operations
May 8, 2023 May 8, 2023
CORRESP Letter to the SEC May 4, 2023 —
DEFA14A Additional proxy material Apr 28, 2023 —
DEF 14A Proxy statement Apr 28, 2023 Jun 15, 2023
8-K Current report
Other events
Apr 24, 2023 Apr 21, 2023
4 Insider transaction Apr 3, 2023 Mar 31, 2023
8-K Current report
Officer or director change
Apr 3, 2023 Mar 29, 2023
UPLOAD Letter from the SEC Mar 31, 2023 —
8-K Current report
Agreement ended
Mar 29, 2023 Mar 28, 2023
S-3 Shelf registration Mar 29, 2023 —
S-8 Employee stock plan registration Mar 28, 2023 —
10-K Annual report Mar 28, 2023 Dec 31, 2022
8-K Current report
Results of operations
Mar 28, 2023 Mar 28, 2023
8-K Current report
Regulation FD disclosure
Mar 13, 2023 Mar 10, 2023
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2023 —
SC 13G Ownership over 5% (passive) Feb 13, 2023 —
SC 13G/A Amended ownership over 5% (passive) Feb 10, 2023 —
SC 13G/A Amended ownership over 5% (passive) Jan 30, 2023 —
4 Insider transaction Dec 20, 2022 Dec 20, 2022
4 Insider transaction Dec 15, 2022 Dec 13, 2022
4 Insider transaction Dec 15, 2022 Dec 13, 2022
8-K/A Amended current report
Shareholder vote results
Nov 3, 2022 Jun 15, 2022
8-K Current report
Results of operations
Nov 3, 2022 Nov 3, 2022
10-Q Quarterly report Nov 3, 2022 Sep 30, 2022
8-K Current report
Listing notice
Oct 28, 2022 Oct 25, 2022
4 Insider transaction Sep 28, 2022 Sep 28, 2022
4 Insider transaction Sep 20, 2022 Sep 20, 2022
4 Insider transaction Aug 15, 2022 Aug 11, 2022
4 Insider transaction Aug 15, 2022 Aug 11, 2022
4 Insider transaction Aug 15, 2022 Aug 11, 2022
4 Insider transaction Aug 15, 2022 Aug 11, 2022
4 Insider transaction Aug 15, 2022 Aug 11, 2022
4 Insider transaction Aug 15, 2022 Aug 11, 2022
4 Insider transaction Aug 15, 2022 Aug 11, 2022
4 Insider transaction Aug 15, 2022 Aug 11, 2022
4 Insider transaction Aug 15, 2022 Aug 11, 2022
4 Insider transaction Aug 15, 2022 Aug 11, 2022
10-Q Quarterly report Aug 8, 2022 Jun 30, 2022
8-K Current report
Results of operations
Aug 8, 2022 Aug 8, 2022
4 Insider transaction Jun 28, 2022 Jun 24, 2022
4 Insider transaction Jun 17, 2022 Jun 15, 2022
4 Insider transaction Jun 17, 2022 Jun 15, 2022
4 Insider transaction Jun 17, 2022 Jun 15, 2022
4 Insider transaction Jun 17, 2022 Jun 15, 2022
4 Insider transaction Jun 17, 2022 Jun 15, 2022
4 Insider transaction Jun 17, 2022 Jun 15, 2022
8-K Current report
Shareholder vote results
Jun 17, 2022 Jun 15, 2022
4 Insider transaction Jun 6, 2022 Jun 2, 2022
S-8 Employee stock plan registration May 5, 2022 —
10-Q Quarterly report May 5, 2022 Mar 31, 2022

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
CRVS (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
South San Francisco, CA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1626971

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.